Solvation directed drug design: from molecular physics to lead optimization
Solvation directed drug design: from molecular physics to lead optimization
批准号:
10664834
负责人:
Thomas Philip Kurtzman
金额:
$37.98万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-15 至 2027-04-30
关键词:
2019-nCoVBindingBinding ProteinsComputer softwareComputing MethodologiesDatabasesDiseaseDockingDrug DesignDrug TargetingHydration statusLeadMapsMembrane ProteinsMethodsModificationMolecularPatternPeptide HydrolasesPharmaceutical PreparationsPhysicsProcessProteinsScientistShapesSpeedStructureSurfaceThermodynamicsWaterWorkcomputerized toolsdesigndrug candidatedrug discoveryimprovedlead optimizationmu opioid receptorspharmacophoretoolvirtualvirtual screening
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
This project aims to develop new methods and computational tools that will speed structure-based drug-
discovery and apply these methods to identify new lead drug candidates for the mu-opioid receptor and SARS-
CoV-2 main proteases. This will be accomplished by providing a detailed analysis of hydration structure and
thermodynamics in targeted protein binding pockets then incorporating this information into docking and
water-based pharmacophore virtual screens. Key aims are to develop analysis tools that characterize and map
out solvation on the surfaces of drug target then utilize these solvation structural and thermodynamic maps to
improve computational methods of binding pocket druggability, virtual screening of purchasable compound
databases, and rational lead modification. Preliminary results for a new method of virtual screening that
combines constructing pharmacophores based on water-protein interactions with ROCS fast shape and pattern
matching show the method is greater than 3 orders of magnitude faster than computational docking.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Solvation directed drug design: from molecular physics to lead optimization
-
批准号:10330792
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2022
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Solvation Directed Design of Flavonoid Derivatives for Caspase Inhibition
-
批准号:8214271
-
项目类别:
-
资助金额:$11.41万
-
财政年份:2012
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Solvation Directed Design of Flavonoid Derivatives for Caspase Inhibition
-
批准号:8458118
-
项目类别:
-
资助金额:$11.01万
-
财政年份:2012
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Exploiting Solvation Structure and Thermodynamics for Prospective Drug Discovery and Rational Design
-
批准号:9461105
-
项目类别:
-
资助金额:$12.38万
-
财政年份:2012
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Exploiting Solvation Structure and Thermodynamics for Prospective Drug Discovery and Rational Design
-
批准号:9278586
-
项目类别:
-
资助金额:$12.38万
-
财政年份:2012
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Solvation Directed Design of Flavonoid Derivatives for Caspase Inhibition
-
批准号:8606468
-
项目类别:
-
资助金额:$11.44万
-
财政年份:2012
-
负责人:Thomas Philip Kurtzman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: